D-0852-2022 Class II Terminated

Recalled by Torrent Pharma Inc — Levittown, PA

FDA drug recall D-0852-2022 was initiated by Torrent Pharma Inc on Apr 11, 2022 and is designated Class II. Reason for recall: CGMP deviations: tablets cracking The recall status is terminated (terminated Jul 25, 2023). Affected quantity: 24,888 bottles.

Recall details

Product Type
Drugs
Report Date
May 11, 2022
Initiation Date
Apr 11, 2022
Termination Date
Jul 25, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,888 bottles

Product description

Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., Levittown, PA 19057, NDC# 13668-096-90.

Reason for recall

CGMP deviations: tablets cracking

Distribution pattern

Nationwide in the U.S.A

Code information

Lot #s: BA34G021, BA34G022, Exp. 09/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0852-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0852-2022. Report a data issue: hello@regdatalab.com.